Updated Jul 16, 2026
SCHULER JACK W has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $7.11M. Lifetime open-market sales: $314K. Historical track record: 3/5 stars across 13 tracked purchases.

Jack W. Schuler is a corporate insider known for his roles as a director and significant shareholder in various companies, including Accelerate Diagnostics, Inc. and Biodesix Inc. He has been involved in the diagnostic solutions sector, particularly focusing on lung disease.
| Role | 10% Owner |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★☆☆ (3/5) |
|---|---|
| Total purchases tracked | 13 |
| Purchases with forward-return data | 13 |
| 30-day win rate | 5385% |
| 90-day win rate | 4615% |
| Avg 5-day return | +1114.57% |
| Avg 30-day return | +766.54% |
| Avg 90-day return | +159.65% |
| Best 30-day return | +3193.28% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-09 | AWHL | Aspira Women's Health Inc. | P — Open-market purchase | 222.2K | $0.45 | $100K |
| 2026-01-27 | BDSX | BIODESIX INC | P — Open-market purchase | 20.0K | $11.80 | $236K |
| 2026-01-27 | BDSX | BIODESIX INC | P — Open-market purchase | 80.0K | $11.81 | $945K |
| 2026-01-26 | BDSX | BIODESIX INC | P — Open-market purchase | 82.5K | $10.96 | $904K |
| 2025-09-19 | BDSX | BIODESIX INC | P — Open-market purchase | 142.0K | $7.04 | $1000K |
| 2025-09-17 | AWHL | Aspira Women's Health Inc. | P — Open-market purchase | 1.11M | $0.45 | $500K |
| 2025-09-17 | BDSX | BIODESIX INC | P — Open-market purchase | 3.1K | $6.17 | $19K |
| 2025-09-17 | BDSX | BIODESIX INC | P — Open-market purchase | 15.3K | $6.04 | $93K |
| 2025-08-29 | BDSX | BIODESIX INC | P — Open-market purchase | 3.49M | $0.43 | $1.50M |
| 2025-05-16 | BDSX | BIODESIX INC | P — Open-market purchase | 723.2K | $0.34 | $247K |
| 2025-05-16 | BDSX | BIODESIX INC | P — Open-market purchase | 4.00M | $0.27 | $1.07M |
| 2024-12-03 | AXDX | Accelerate Diagnostics, Inc | S — Open-market sale | 200.0K | $1.57 | $314K |
| 2024-11-22 | BDSX | BIODESIX INC | P — Open-market purchase | 100.0K | $1.23 | $123K |
| 2024-11-21 | BDSX | BIODESIX INC | P — Open-market purchase | 200.0K | $1.17 | $234K |
| 2024-11-06 | BDSX | BIODESIX INC | P — Open-market purchase | 100.3K | $1.36 | $137K |
Jack W. Schuler is a corporate insider known for his roles as a director and significant shareholder in various companies, including Accelerate Diagnostics, Inc. and Biodesix Inc. He has been involved in the diagnostic solutions sector, particularly focusing on lung disease.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 16 open-market purchases ($7.11M) and 1 open-market sales ($314K) across all tracked filings.
Across 13 tracked purchases, SCHULER JACK W averaged +766.5% avg 30-day return with a 5385% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SCHULER JACK W profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.